Cybin announces streamlined clinical alignment

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing psychedelics to therapeutics® today announced a streamlining plan aimed at maximizing the company's operating efficiency and to allow the company to focus on critical clinical trials.

CYBN Ratings Summary

CYBN Quant Ranking